肝門部膽管癌的淋巴結廓清—進展與實踐_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

黃鑫 ¹ , 李莉 ² , 毛諒 ³ ,  項燦宏 ¹

1. ;
2. ;
3. ;

Corresponding?author：

項燦宏, Email: roy.xx@163.com

Keywords：

DOI：

10.7507/1007-9424.202002026

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 黃鑫, 李莉, 毛諒, 項燦宏. 肝門部膽管癌的淋巴結廓清—進展與實踐. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(3): 274-277. doi: 10.7507/1007-9424.202002026 Copy

1.	Nagakawa T, Kayahara M, Ikeda S, et al. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg, 2002, 9(5): 569-575.
2.	Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford), 2005, 7(4): 259-262.
3.	董家鴻, 馮曉彬. 精準外科時代的肝門部膽管癌治療. 中華消化外科雜志, 2019, 18(4): 307-310.
4.	董家鴻, 項燦宏, 石軍, 等. 以圍肝門切除為本的肝門部膽管癌治愈性切除術的臨床療效. 中華消化外科雜志, 2017, 16(10): 1053-1060.
5.	Bagante F, Tran T, Spolverato G, et al. Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg, 2016, 222(5): 750-759.
6.	李富宇, 程南生, 馬文杰. 肝門部膽管癌根治與淋巴結清掃范圍. 中國普外基礎與臨床雜志, 2018, 25(8): 993-996.
7.	Greene FL, Page DL, FIeming ID, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 6th ed. New York: Springer, 2002.
8.	Edge S, Byrd D, Compton CC, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 7th ed. New York: Springer, 2010.
9.	Amin MB, Edge S, Greene F, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 8th ed. New York: Springer, 2017.
10.	毛諒, 陳駿, 孫士全, 等. 美國癌癥聯合委員會肝門部膽管癌分期系統(第8版)更新解讀. 中國實用外科雜志, 2017, 37(5): 510-513.
11.	Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
12.	Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 2001, 233(3): 385-392.
13.	Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg, 2013, 257(4): 718-725.
14.	Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis. JAMA Surg, 2016, 151(10): 916-922.
15.	Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg, 2015, 210(4): 694-701.
16.	Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg, 2010, 251(4): 675-681.
17.	Mao K, Liu J, Sun J, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol, 2016, 31(2): 417-426.
18.	Hakeem AR, Marangoni G, Chapman SJ, et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol, 2014, 26(9): 1047-1054.
19.	Conci S, Ruzzenente A, Sandri M, et al. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol, 2017, 43(4): 743-750.
20.	Guglielmi A, Ruzzenente A, Campagnaro T, et al. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford), 2011, 13(4): 240-245.
21.	Kiriyama M, Ebata T, Aoba T, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg, 2015, 102(4): 399-406.
22.	Taniguchi K, Tabata M, Iida T, et al. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol, 2006, 32(2): 208-212.
23.	Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg, 2009, 96(5): 509-516.
24.	Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg, 2010, 252(1): 99-106.
25.	Mantel HT, Wiggers JK, Verheij J, et al. Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg Oncol, 2015, 22(Suppl 3): S1107-S1115.

1. Nagakawa T, Kayahara M, Ikeda S, et al. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg, 2002, 9(5): 569-575.
2. Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford), 2005, 7(4): 259-262.
3. 董家鴻, 馮曉彬. 精準外科時代的肝門部膽管癌治療. 中華消化外科雜志, 2019, 18(4): 307-310.
4. 董家鴻, 項燦宏, 石軍, 等. 以圍肝門切除為本的肝門部膽管癌治愈性切除術的臨床療效. 中華消化外科雜志, 2017, 16(10): 1053-1060.
5. Bagante F, Tran T, Spolverato G, et al. Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg, 2016, 222(5): 750-759.
6. 李富宇, 程南生, 馬文杰. 肝門部膽管癌根治與淋巴結清掃范圍. 中國普外基礎與臨床雜志, 2018, 25(8): 993-996.
7. Greene FL, Page DL, FIeming ID, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 6th ed. New York: Springer, 2002.
8. Edge S, Byrd D, Compton CC, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 7th ed. New York: Springer, 2010.
9. Amin MB, Edge S, Greene F, et al. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 8th ed. New York: Springer, 2017.
10. 毛諒, 陳駿, 孫士全, 等. 美國癌癥聯合委員會肝門部膽管癌分期系統(第8版)更新解讀. 中國實用外科雜志, 2017, 37(5): 510-513.
11. Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
12. Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 2001, 233(3): 385-392.
13. Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg, 2013, 257(4): 718-725.
14. Giuliante F, Ardito F, Guglielmi A, et al. Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis. JAMA Surg, 2016, 151(10): 916-922.
15. Kambakamba P, Linecker M, Slankamenac K, et al. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg, 2015, 210(4): 694-701.
16. Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg, 2010, 251(4): 675-681.
17. Mao K, Liu J, Sun J, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol, 2016, 31(2): 417-426.
18. Hakeem AR, Marangoni G, Chapman SJ, et al. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol, 2014, 26(9): 1047-1054.
19. Conci S, Ruzzenente A, Sandri M, et al. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol, 2017, 43(4): 743-750.
20. Guglielmi A, Ruzzenente A, Campagnaro T, et al. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford), 2011, 13(4): 240-245.
21. Kiriyama M, Ebata T, Aoba T, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg, 2015, 102(4): 399-406.
22. Taniguchi K, Tabata M, Iida T, et al. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol, 2006, 32(2): 208-212.
23. Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of para-aortic lymph node micrometastasis in patients with regional node-positive biliary cancer. Br J Surg, 2009, 96(5): 509-516.
24. Yonemori A, Kondo S, Matsuno Y, et al. Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg, 2010, 252(1): 99-106.
25. Mantel HT, Wiggers JK, Verheij J, et al. Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg Oncol, 2015, 22(Suppl 3): S1107-S1115.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝門部膽管癌的淋巴結廓清—進展與實踐

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content